Travere Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Travere Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2012 to Q3 2024.
  • Travere Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.02M, a 29.1% decline year-over-year.
  • Travere Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $35.8M, a 20.1% decline year-over-year.
  • Travere Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.2M, a 16% increase from 2022.
  • Travere Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $38.1M, a 29% increase from 2021.
  • Travere Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.6M, a 25.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $35.8M $8.02M -$3.3M -29.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $39.1M $9.92M -$1.39M -12.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $40.5M $9.76M -$3.71M -27.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $44.2M $8.14M -$589K -6.75% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $44.8M $11.3M +$2.73M +31.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $42.1M $11.3M -$1.33M -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $43.4M $13.5M +$5.29M +64.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $38.1M $8.73M +$1.36M +18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $36.8M $8.59M +$1.6M +22.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $35.2M $12.6M +$5.13M +68.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $30.1M $8.19M +$492K +6.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $29.6M $7.38M +$1.02M +16.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $28.5M $6.99M +$1.59M +29.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $27M $7.51M +$1.56M +26.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $25.4M $7.69M +$1.78M +30.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $23.6M $6.35M +$1.86M +41.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $21.8M $5.4M +$1.06M +24.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $20.7M $5.95M +$206K +3.58% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $20.5M $5.91M -$610K -9.36% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $21.1M $4.5M -$357K -7.36% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $21.5M $4.34M -$545K -11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $22M $5.75M +$322K +5.93% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $21.7M $6.52M +$1.91M +41.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $19.8M $4.85M -$728K -13% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $20.5M $4.89M -$2.08M -29.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $22.6M $5.43M -$1.81M -25% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $24.4M $4.61M -$2.48M -35% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $26.9M $5.58M -$1.49M -21% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $28.4M $6.96M -$788K -10.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $29.1M $7.24M -$254K -3.39% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $29.4M $7.09M +$300K +4.42% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-07-06
Q4 2016 $29.1M $7.07M -$84K -1.17% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $29.2M $7.75M -$433K -5.29% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $29.6M $7.49M +$2.5M +50% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $27.1M $6.79M +$1.22M +21.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $25.9M $7.15M +$489K +7.34% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
Q3 2015 $25.4M $8.18M +$4.98M +155% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $20.4M $4.99M +$2.37M +90% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $18.1M $5.57M +$2.17M +63.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $15.9M $6.66M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $3.2M +$1.46M +83.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $2.63M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $3.4M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 $1.74M -$5.29M -75.2% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-07-09
Q3 2012 $7.03M Jul 1, 2012 Sep 30, 2012 10-Q/A 2015-07-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.